Benchmark Dose Determining Airborne Crystalline Silica Particles Based on A549 Lung-cell Line Survival in an in Vitro Study

Overview

Journal Sci Rep

Specialty Science

Date 2024 Sep 13

PMID 39271741

Authors

Athena Rafieepour

Masoomeh Vahabi Shekarloo

Azadeh Ashtarinezhad

Iraj Alimohammadi

Zahra Panjali

Affiliations

Soon will be listed here.

Abstract

Crystalline silica has emerged as a prominent occupational toxicant over extended periods, leading to the development of lung disease and cancer. The objective of this investigation is to establish a benchmark dose (BMD) for crystalline silica micro and nanoparticles based on the dehydrogenase activity of the A549 lung-cell line. The impact of exposure to crystalline silica micro-particles (C-SiO MPs) and crystalline silica nanoparticles (C-SiO NPs) on A549 epithelial lung cells was examined for durations of 24 and 72 h to evaluate cell viability using the MTT (3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide) assay. The determination of dose-response and BMD was carried out through the BMD software v 3.2. The findings reveal a dose-dependent relationship between cell viability and both C-SiO MPs and -NPs. The BMDL values for 24 h treatment of C-SiO MPs and -NPs were determined to be 2.26 and 0.97 µg/ml, respectively, based on exponential models. Correspondingly, these values were found to be 1.17 and 0.85 µg/ml for the 72 h treatment. This investigation underscores the significance of particle size as a contributing factor in assessing occupational health risks. Moreover, the utilization of BMDL can facilitate the determination of more precise values for occupational exposures by considering various parameters associated with particle presence.

References

Lin W, Huang Y, Zhou X, Ma Y . In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol Appl Pharmacol. 2006; 217(3):252-9. DOI: 10.1016/j.taap.2006.10.004. View

Rafieepour A, Azari M, Khodagholi F . Cytotoxic effects of crystalline silica in form of micro and nanoparticles on the human lung cell line A549. Toxicol Ind Health. 2022; 39(1):23-35. DOI: 10.1177/07482337221140644. View

Chauhan V, Yu J, Vuong N, Haber L, Williams A, Auerbach S . Considerations for application of benchmark dose modeling in radiation research: workshop highlights. Int J Radiat Biol. 2023; 99(9):1320-1331. DOI: 10.1080/09553002.2023.2181998. View

Murugadoss S, Lison D, Godderis L, van den Brule S, Mast J, Brassinne F . Toxicology of silica nanoparticles: an update. Arch Toxicol. 2017; 91(9):2967-3010. PMC: 5562771. DOI: 10.1007/s00204-017-1993-y. View

Salamon F, Martinelli A, Vianello L, Bizzotto R, Gottardo O, Guarnieri G . Occupational exposure to crystalline silica in artificial stone processing. J Occup Environ Hyg. 2021; 18(12):547-554. DOI: 10.1080/15459624.2021.1990303. View

Jaganathan H, Godin B . Biocompatibility assessment of Si-based nano- and micro-particles. Adv Drug Deliv Rev. 2012; 64(15):1800-19. PMC: 3465530. DOI: 10.1016/j.addr.2012.05.008. View

Mohammadyan M, Rokni M, Yosefinejad R . Occupational exposure to respirable crystalline silica in the Iranian Mazandaran province industry workers. Arh Hig Rada Toksikol. 2013; 64(1):139-43. DOI: 10.2478/10004-1254-64-2013-2284. View

Rafieepour A, Azari M, Jaktaji J, Khodagholi F, Peirovi H, Mehrabi Y . The Effect of Particle Size on the Cytotoxicity of Amorphous Silicon Dioxide: An in Vitro Toxicological Study. Asian Pac J Cancer Prev. 2021; 22(2):325-332. PMC: 8190354. DOI: 10.31557/APJCP.2021.22.2.325. View

Maciejewska A . Occupational exposure assessment for crystalline silica dust: approach in Poland and worldwide. Int J Occup Med Environ Health. 2008; 21(1):1-23. DOI: 10.2478/v10001-008-0010-3. View

10.

Kuempel E, Sweeney L, Morris J, Jarabek A . Advances in Inhalation Dosimetry Models and Methods for Occupational Risk Assessment and Exposure Limit Derivation. J Occup Environ Hyg. 2015; 12 Suppl 1:S18-40. PMC: 4685615. DOI: 10.1080/15459624.2015.1060328. View

11.

Rice F, Stayner L . Assessment of silicosis risk for occupational exposure to crystalline silica. Scand J Work Environ Health. 1995; 21 Suppl 2:87-90. View

12.

Pavan C, Delle Piane M, Gullo M, Filippi F, Fubini B, Hoet P . The puzzling issue of silica toxicity: are silanols bridging the gaps between surface states and pathogenicity?. Part Fibre Toxicol. 2019; 16(1):32. PMC: 6697921. DOI: 10.1186/s12989-019-0315-3. View

13.

Freeman C, Grossman E . Silica exposures in workplaces in the United States between 1980 and 1992. Scand J Work Environ Health. 1995; 21 Suppl 2:47-9. View

14.

Park E, Park K . Oxidative stress and pro-inflammatory responses induced by silica nanoparticles in vivo and in vitro. Toxicol Lett. 2008; 184(1):18-25. DOI: 10.1016/j.toxlet.2008.10.012. View

15.

Shekarloo M, Panjali Z, Mehrifar Y, Ramezanifar S, Naziri S, Ghasemi Koozekonan A . Application of a novel exposure limit approach for co-exposure of ‎chemicals: a field study by in-vitro design. Int J Environ Health Res. 2022; 33(12):1269-1277. DOI: 10.1080/09603123.2022.2084513. View

16.

Liu J, Sayes C . A toxicological profile of silica nanoparticles. Toxicol Res (Camb). 2022; 11(4):565-582. PMC: 9424711. DOI: 10.1093/toxres/tfac038. View

17.

McCarthy J, Inkielewicz-Stepniak I, Corbalan J, Radomski M . Mechanisms of toxicity of amorphous silica nanoparticles on human lung submucosal cells in vitro: protective effects of fisetin. Chem Res Toxicol. 2012; 25(10):2227-35. DOI: 10.1021/tx3002884. View

18.

Ahamed M . Silica nanoparticles-induced cytotoxicity, oxidative stress and apoptosis in cultured A431 and A549 cells. Hum Exp Toxicol. 2013; 32(2):186-95. DOI: 10.1177/0960327112459206. View

19.

Omidianidost A, Ghasemkhani M, Kakooei H, Shahtaheri S, Ghanbari M . Risk Assessment of Occupational Exposure to Crystalline Silica in Small Foundries in Pakdasht, Iran. Iran J Public Health. 2016; 45(1):70-5. PMC: 4822397. View

20.

Rey-Brandariz J, Martinez C, Candal-Pedreira C, Perez-Rios M, Varela-Lema L, Ruano-Ravina A . Occupational exposure to respirable crystalline silica and lung cancer: a systematic review of cut-off points. Environ Health. 2023; 22(1):82. PMC: 10687911. DOI: 10.1186/s12940-023-01036-0. View